Vertex Pharmaceuticals Inc (VRTX)
397.48
-0.22
(-0.06%)
USD |
NASDAQ |
Apr 26, 16:00
397.43
-0.05
(-0.01%)
After-Hours: 20:00
Vertex Pharmaceuticals Gross Profit (TTM): 8.607B for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 8.607B |
September 30, 2023 | 8.477B |
June 30, 2023 | 8.357B |
March 31, 2023 | 8.107B |
December 31, 2022 | 7.850B |
September 30, 2022 | 7.656B |
June 30, 2022 | 7.359B |
March 31, 2022 | 6.990B |
December 31, 2021 | 6.670B |
September 30, 2021 | 6.270B |
June 30, 2021 | 5.874B |
March 31, 2021 | 5.649B |
December 31, 2020 | 5.469B |
September 30, 2020 | 5.273B |
June 30, 2020 | 4.739B |
March 31, 2020 | 4.204B |
December 31, 2019 | 3.615B |
September 30, 2019 | 3.135B |
June 30, 2019 | 2.990B |
March 31, 2019 | 2.832B |
December 31, 2018 | 2.638B |
September 30, 2018 | 2.458B |
June 30, 2018 | 2.290B |
March 31, 2018 | 2.115B |
December 31, 2017 | 2.214B |
Date | Value |
---|---|
September 30, 2017 | 2.044B |
June 30, 2017 | 1.899B |
March 31, 2017 | 1.812B |
December 31, 2016 | 1.492B |
September 30, 2016 | 1.448B |
June 30, 2016 | 1.366B |
March 31, 2016 | 1.129B |
December 31, 2015 | 907.82M |
September 30, 2015 | 683.80M |
June 30, 2015 | 570.75M |
March 31, 2015 | 542.66M |
December 31, 2014 | 519.43M |
September 30, 2014 | 717.79M |
June 30, 2014 | 747.35M |
March 31, 2014 | 899.05M |
December 31, 2013 | 1.082B |
September 30, 2013 | 999.08M |
June 30, 2013 | 1.102B |
March 31, 2013 | 1.133B |
December 31, 2012 | 1.247B |
September 30, 2012 | 1.534B |
June 30, 2012 | 1.857B |
March 31, 2012 | 1.659B |
December 31, 2011 | 1.330B |
September 30, 2011 | 859.38M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
2.990B
Minimum
Jun 2019
8.607B
Maximum
Dec 2023
6.173B
Average
6.270B
Median
Sep 2021
Gross Profit (TTM) Benchmarks
Amgen Inc | 19.74B |
Eli Lilly and Co | 27.04B |
Regeneron Pharmaceuticals Inc | 11.30B |
Alpine Immune Sciences Inc | -- |
Moderna Inc | 2.061B |